<DOC>
	<DOCNO>NCT00919737</DOCNO>
	<brief_summary>The purpose study evaluate whether NPC-08 safety efficacy treatment newly-diagnosed malignant glioma recurrent glioblastoma multiforme .</brief_summary>
	<brief_title>Study NPC-08 Treat Newly-Diagnosed Malignant Glioma Recurrent Glioblastoma Multiforme</brief_title>
	<detailed_description />
	<mesh_term>Glioblastoma</mesh_term>
	<mesh_term>Glioma</mesh_term>
	<mesh_term>Carmustine</mesh_term>
	<criteria>Male female , age 18 65 year ; Radiographic evidence cranial MRI single contrastenhancing unilateral supratentorial cerebral tumor ; Karnofsky Performance Score 60 high ; Willing practice effective method birth control least 12 month wafer implantation surgery ; More one focus tumor tumor cross midline , assess coronal cranial MRI scan ; Prior radiotherapy brain ; Prior chemotherapy malignant glioma baseline evaluation , patient treat chemotherapeutic agent ; Known hypersensitivity nitrosoureas ; Participation investigational protocol previous 6 month type malignancy ;</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>October 2013</verification_date>
	<keyword>NPC-08</keyword>
	<keyword>carmustine</keyword>
	<keyword>nitrosourea</keyword>
	<keyword>safety</keyword>
</DOC>